Search Results - "Huber, Severine"

Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria by Hennenlotter, Joerg, Huber, Severine, Todenhöfer, Tilman, Kuehs, Ursula, Schilling, David, Aufderklamm, Stefan, Gakis, Georgios, Schwentner, Christian, Stenzl, Arnulf

“…Introduction. Several point-of-care tests (POCT) are available for the diagnosis of bladder cancer (BC). We evaluate the impact of HU (hematuria) on…”
Get full text

Nuclear matrix protein‐22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study by Huber, Severine, Schwentner, Christian, Taeger, Dirk, Pesch, Beate, Nasterlack, Michael, Leng, Gabriele, Mayer, Thomas, Gawrych, Katarzyna, Bonberg, Nadin, Pelster, Martin, Johnen, Georg, Bontrup, Heike, Wellhäußer, Harald, Bierfreund, Hans‐Georg, Wiens, Christian, Bayer, Christian, Eberle, Friedhelm, Scheuermann, Bernd, Kluckert, Mattias, Feil, Gerhard, Brüning, Thomas, Stenzl, Arnulf

“…Study Type – Diagnostic (non‐consecutive cohort without consistently applied reference standard) Level of Evidence 3b What's known on the subject? and What…”
Get full text

NMP22 as a urine-based tumour marker for bladder cancer screening in a prospective cohort of chemical workers formerly exposed to aromatic amines: results of the UroScreen study by Taeger, Dirk, Pesch, Beate, Huber, Severine, Nasterlack, Michael, Leng, Gabriele, Mayer, Thomas, Gawrych, Katarzyna, Bonberg, Nadine, Wellhäußer, Harald, Kluckert, Matthias, Johnen, Georg, Stenzl, Arnulf, Brüning, Thomas

“…Objectives Cancer of the urinary bladder ranks among the four leading cancers among men in Germany. Because bladder cancer can be successfully treated,…”
Get full text